Diabetes News and Research

Latest Diabetes News and Research

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Diabetes care is undergoing a paradigm shift in which insulin is being prescribed earlier, for more conditions, in order to delay the onset of full-blown disease, according to a study released today by Scientia Advisors.

14 Oct 2009

Aptiom to acquire all outstanding shares of common stock of Sepracor

Dainippon Sumitomo Pharma Co., Ltd. (“DSP”) and Sepracor Inc. (“Sepracor”) (NASDAQ: SEPR) today announce the successful completion of the tender offer by DSP’s indirect wholly-owned subsidiary, Aptiom, Inc. (“Offeror”), to acquire all outstanding shares of common stock of Sepracor for $23.00 per share in cash.

14 Oct 2009

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Antisense Therapeutics Limited is pleased to announce that the Company has now completed repeat-dosing toxicology studies for ATL1103 in two species -- mouse and non-human primate. Draft study reports from the study contractors in the United States have been received, and the toxicology outcomes from these studies support ANP's plans for the continued development of ATL1103.

14 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

State-level education policy essential to reverse childhood obesity

The new issue of The State Education Standard, the journal of the National Association of State Boards of Education (NASBE), examines how education policymakers can best address childhood obesity in school settings.

14 Oct 2009

VIA Pharmaceuticals receives determination letter from NASDAQ Stock Market

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, today announced that on October 9, 2009, it received a determination letter from The NASDAQ Stock Market notifying the Company that the NASDAQ Hearing Panel (the "Panel") has granted the Company's request to remain listed on NASDAQ, subject to the Company demonstrating compliance with the NASDAQ Listing Rules (the "Listing Rules") on or before December 31, 2009 (the "Exception Period").

14 Oct 2009

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

According to a new report distributed by Life Science Intelligence (LSI), the global point-of-care (POC) testing market will experience dramatic growth from $12.8 billion in 2008 to $17.8 billion by 2014.

14 Oct 2009

T.S. Wiley to lecture on the latest advances in anti-aging medicine

Wiley Systems™, Inc. announces that internationally acclaimed Author T.S. Wiley will be lecturing at the second annual European Congress on Anti-Aging & Aesthetic Medicine (ECAAAM) at the Congress Centre, Mainz, near Frankfurt, October 15-17, 2009. Wiley will give two lectures among other international experts presenting the latest advances in anti-aging medicine.

14 Oct 2009

Increase in adiponectin hormone levels protects against sepsis-related mortality

A hormone naturally found in the fat that surrounds the abdominal organs for the first time has been linked to death related to sepsis, surgeons reported at the 2009 Clinical Congress of the American College of Surgeons. A study exhibited at the conference showed that low levels of the hormone adiponectin placed animals at a profoundly high risk of death from a septic insult.

14 Oct 2009

National study shows people who work after retiring experience fewer major diseases

Retirees who transition from full-time work into a temporary or part-time job experience fewer major diseases and are able to function better day-to-day than people who stop working altogether, according to a national study. And the findings were significant even after controlling for people's physical and mental health before retirement.

14 Oct 2009

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

Galapagos NV announced today that it has expanded its global strategic alliance in metabolic diseases with an affiliate of Merck & Co., Inc to incorporate the development of new therapies for atherosclerosis.

14 Oct 2009

National Vaccine Information Center to launch a research fundraising campaign

At the Oct. 2-4, 2009 Fourth International Public Conference on Vaccination sponsored by the non-profit National Vaccine Information Center in Reston, VA, 700 citizens from 44 states and 11 nations raised more than $100,000 to launch an international scientific research fundraising campaign to investigate health differences between vaccinated and unvaccinated children and identify those at risk for suffering vaccine injury.

14 Oct 2009

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Metabolic Solutions Development Company (MSDC) announced today that it has received a $100,000 grant from the Alzheimer's Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential treatment for Alzheimer's disease.

14 Oct 2009

Scientists identify the first genetic mechanism that generates the cerebral cortex

The cerebral cortex, the largest and most complex component of the brain, is unique to mammals and alone has evolved human specializations. Although at first all stem cells in charge of building the cerebral cortex-the outermost layer of neurons commonly referred to as gray matter-are created equal, soon they irrevocably commit to forming specific cortical regions. But how the stem cells' destiny is determined has remained an open question.

14 Oct 2009

American Recovery and Reinvestment Act funds to support research in numerous health areas

As part of the $5 billion in grants announced by President Obama, the National Institutes of Health has granted Kaiser Permanente more than $54 million over two years through the American Recovery and Reinvestment Act to conduct health research on a multitude of critical public and clinical health areas.

14 Oct 2009

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Vanda Pharmaceuticals Inc. announced today that it has entered into an agreement with Novartis Pharma AG to commercialize and develop Fanapt(TM) (iloperidone), Vanda's anti-psychotic, in the U.S. and Canada. Fanapt(TM) was approved by the U.S. Food and Drug Administration on May 6, 2009 for the acute treatment of schizophrenia in adults.

14 Oct 2009

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.

14 Oct 2009

American Lung Association to raise awareness about the seriousness of seasonal influenza

In the spirit of "healthy competition," the American Lung Association in Minnesota is teaming up with the Minneapolis and St. Paul Fire Departments to raise awareness about the seriousness of seasonal influenza and the importance of vaccination this year.

14 Oct 2009

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft (“Augment”), to autograft for use in hindfoot and ankle fusion surgery.

14 Oct 2009

Timely and individualized publicly funded therapy denied to children with autism

With October being Autism Awareness Month in Canada, Ontarians should be aware of the increasingly large gaps in services for children with autism in this province.

14 Oct 2009

Diabetes News and Research

Latest Diabetes News and Research

Diabetes care undergoes a paradigm shift to delay onset of full-blown disease

Aptiom to acquire all outstanding shares of common stock of Sepracor

Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103

Brain researcher finds how the epilepsy and pain drug works

State-level education policy essential to reverse childhood obesity

VIA Pharmaceuticals receives determination letter from NASDAQ Stock Market

Global POC market to increase from $12.8 billion in 2008 to $17.8 billion by 2014, says report

T.S. Wiley to lecture on the latest advances in anti-aging medicine

Increase in adiponectin hormone levels protects against sepsis-related mortality

National study shows people who work after retiring experience fewer major diseases

Galapagos extends collaboration with Merck to develop new therapies for atherosclerosis

National Vaccine Information Center to launch a research fundraising campaign

ADDF grant to support the evaluation of PPAR-sparing insulin sensitizers

Scientists identify the first genetic mechanism that generates the cerebral cortex

American Recovery and Reinvestment Act funds to support research in numerous health areas

Vanda Pharmaceuticals announces its agreement with Novartis Pharma AG

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

American Lung Association to raise awareness about the seriousness of seasonal influenza

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

Timely and individualized publicly funded therapy denied to children with autism

Industry Focus eBook - Medical device (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in